Terazosin Hcl
Brand names: Terazosin Hcl
At a glance
- Medicare prescriptions, 2024
- 859,973
- Medicare drug cost
- $20.4M
- Average cost per prescription
- $23.70
- Clinicians who prescribed it
- 33,453
Where it is prescribed
List the prescribers in any state, county, city or ZIP code →
What it is used for
Terazosin capsules, USP are indicated for the treatment of symptomatic benign prostatic hyperplasia (BPH). There is a rapid response, with approximately 70% of patients experiencing an increase in urinary flow and improvement in symptoms of BPH when treated with terazosin capsules, USP. The long-term effects of terazosin capsules, USP on the incidence of surgery, acute urinary obstruction or other complications of BPH are yet to be determined.
From the FDA-approved prescribing information (label dated September 2026). Full labels on DailyMed (opens in a new tab)
Who prescribes it
- Family Medicine 37.3%
- Internal Medicine 31.3%
- Urology 7.8%
- Nurse Practitioners 7.4%
- Cardiology 3.6%
- Physician Assistants 3.3%
- Nephrology (Kidney) 3.1%
- General Practice 1.4%
- Geriatric Medicine 1.3%
- Interventional Cardiology 1.0%
- Hospitalist 0.4%
- Infectious Disease 0.2%
All prescribers, by place, name or specialty →
Share of Medicare prescriptions written by each specialty. Select one to list its prescribers.
Trend, 2019–2024
Medicare prescriptions fell 25% from 2019 to 2024.
Biggest change by state since 2019
- Idaho −16%
- Washington −16%
- Hawaii −17%
- California −20%
- Arkansas −20%
- Colorado (smallest change) −51%
- Rhode Island (smallest change) −37%
From CMS’s yearly state and national Part D summaries, which count every prescriber, including those CMS leaves out of its per-clinician data (fewer than 11 prescriptions). That is why these totals are higher than the count at the top of this page. Prescriptions include refills.
What it looks like
Pills from 1 maker on file. The same medicine can look different depending on who made it, so check the imprint (the letters and numbers on the pill) with your pharmacist if a refill looks different.
Amerisyn LLC
| Strength | Looks like | Imprint |
|---|---|---|
| 1 mg | white capsule, 16 mm | AP781 |
| 2 mg | yellow capsule, 16 mm | AP782 |
| 5 mg | pink capsule, 16 mm | AP783 |
| 10 mg | turquoise capsule, 16 mm | AP784 |
Source: DailyMed (U.S. National Library of Medicine), from each maker’s FDA drug listing. A few makers are shown, not every one. Never take a pill you can’t identify; ask a pharmacist.
Industry payments about this drug
No industry payments to clinicians named this drug in 2025.
Recalls and shortages
Not on the FDA drug shortage list.
No FDA-reported recalls since 2020.
Sources: CMS Medicare Part D Prescribers by Provider and Drug (2024; prescriptions include refills, and CMS hides counts under 11 per prescriber); U.S. Food and Drug Administration, openFDA (drug labels, NDC directory, enforcement reports, drug shortages); CMS Open Payments 2025; ClinicalTrials.gov. General information only, not medical advice; not yet reviewed by our medical reviewer.